Dr. Tom Lietman, MD
Claim this profileUniversity of California, San Francisco
Studies Trachomatous Trichiasis
Studies Trachoma
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Tom Lietman, MD is currently running
Azithromycin
for Trachoma
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Recruiting3 awards Phase 4
Azithromycin
for Child Mortality
This trial will investigate the supplementation of azithromycin distribution to the "Child Health Days" platform in Burkina Faso for child mortality reduction. This distribution will pair door-to-door administration of vitamin A and azithromycin or placebo with acute malnutrition screening among children 1-11 months old.
Recruiting2 awards Phase 42 criteria
More about Tom Lietman, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Tom Lietman, MD has experience with
- Azithromycin
- Chlorhexidine Gluconate
- Moxifloxacin Ophthalmic
- Natamycin
- Rose Bengal Electromagnetic Activation
- Placebo
Breakdown of trials Tom Lietman, MD has run
Trachomatous Trichiasis
Trachoma
Implementation
Antibiotic Resistance
Mortality
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tom Lietman, MD specialize in?
Tom Lietman, MD focuses on Trachomatous Trichiasis and Trachoma. In particular, much of their work with Trachomatous Trichiasis has involved treating patients, or patients who are undergoing treatment.
Is Tom Lietman, MD currently recruiting for clinical trials?
Yes, Tom Lietman, MD is currently recruiting for 3 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Tom Lietman, MD has studied deeply?
Yes, Tom Lietman, MD has studied treatments such as Azithromycin, Chlorhexidine Gluconate, Moxifloxacin Ophthalmic.
What is the best way to schedule an appointment with Tom Lietman, MD?
Apply for one of the trials that Tom Lietman, MD is conducting.
What is the office address of Tom Lietman, MD?
The office of Tom Lietman, MD is located at: University of California, San Francisco, San Francisco, California 94158 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.